BRCA1 and ovarian cancer: Furthermore, under comparable personal and family histories of breast and/or ovarian cancer, the Japanese population demonstrates a higher prevalence of BRCA1/2 pathogenic variants than the general non-Ashkenazi population (odds ratio = 1.87).116